: [1535][1536][1537][1538][1539][1540][1541][1542] Long-term morbidity with endovascular and open repair of AAAs appears to be similar.
PDA to the Rescue

A Computerized Handheld Decision-Support System to Improve Pulmonary Embolism Diagnosis: A Randomized Trial.
Roy P-M, Durieux P, et al: Ann Intern Med 2009; 151 (November 17): 677-686 Diagnostic decision-making for patients with suspected PE in an ED setting is significantly improved with the use of a handheld decision-support system.
Background:
In practice, the work-up for pulmonary embolism (PE) frequently differs from that recommended by evidence-based guidelines. Clinical probability estimates have previously been shown to be efficient, accurate, and safe. Objective: To evaluate whether the use of a handheld clinical decision-support system is effective at improving the work-up and diagnosis of patients with suspected PE in the emergency department (ED). Design: Nonblinded, cluster randomized trial. Participants/Methods: This study involved 20 EDs in France assessing consecutive outpatients with suspected PE. A 6-month preintervention period, involving 1103 patients, preceded the actual trial; during this time, providers grew accustomed to inputting clinical data into handheld devices, and investigators assessed baseline testing. EDs were then randomly assigned to either activation of a handheld decision-support system (10 centers, 753 patients) or use of posters and pocket cards that displayed validated diagnostic strategies (10 centers, 1015 patients). The primary study outcome was appropriateness of the diagnostic work-up as determined by any sequence of tests that yielded a diagnostic probability of <5% or >85%. Secondary outcomes were strict adherence to guideline recommendations, number of tests per patient, and clinical outcomes at 3 months. Results: Data were inputted in real-time for 557 patients (80%) in the handheld-based guidelines group and 369 patients (39%) in the paper guidelines group. The frequency of appropriate diagnostic work-ups increased in both the handheld decision-support system group and the paper guidelines group from the pre-intervention period to the trial period. However, this increase was statistically and clinically more significant in the handheld decision-support system group, with an absolute change of 30.2% in the handheld-based group versus 10.9% in the paper guidelines group; adjusted mean difference in increase, 19.3 percentage points favoring handheldbased guidelines (95% CI, 2.9 to 35.6 percentage points; P =0.023). The improvement occurred primarily among patients in whom PE was ruled out (P =0.018). In an analysis of patients with appropriate work-ups, the handheld-based guidelines group underwent significantly fewer tests per patient compared to the paper guidelines group (mean, 1.76 [SD, 0.98] vs 2.25 [SD, 1.04]; P <0.001). Conclusions: Diagnostic decision-making for patients with suspected PE in an ED setting is significantly improved with the use of a handheld decision-support system. Reviewer's Comments: There is a growing movement coming from many different directions to standardize health care delivery in a quest to contain costs and provide evidence-based standard-of-care treatment consistently. For example, most hospitals have algorithms directing the physician on how to treat communityand hospital-acquired pneumonias. Although superficially appearing to be a good idea, the precise impact on clinical outcomes is not as conclusive. Case-in-point: this study was not designed to show a difference in the clinical outcomes of patients during follow-up. (Reviewer-Todd A. Kellogg, MD).
Does Breast MRI in Breast Cancer Patients Cause Overtreatment?
The Impact of Breast MRI on Surgical Decision-Making: Are Patients at Risk for Mastectomy?
Pettit K, Swatske ME, et al: J Surg Oncol 2009; 100 (December 1): [553] [554] [555] [556] [557] [558] Breast MRI increases mastectomy rates in newly diagnosed breast cancer patients.
Background: MRI is used to define the extent of disease in the ipsilateral breast and any disease in the contralateral breast in patients with a known diagnosis of breast cancer. The affect this diagnostic test has on subsequent treatment plans is unknown. Objective: To determine if MRI in newly diagnosed breast cancer patients alters surgical decision making and to assess whether mastectomy rates increase with the use of MRI. Design: Retrospective review of newly diagnosed breast cancer patients. Participants: 1,444 patients were identified, of which 492 had a preoperative MRI and 952 did not; 441 MRI patients had complete records. Methods: MRI characteristics were collected. Criteria for suspicious lesions included size, morphology, and contrast kinetics. The number of new lesions on MRI was reported. A change in management was defined when an initial multidisciplinary plan was changed based on MRI findings. A comparison was made of mastectomy rates between patients who had and who did not have a preoperative MRI. Interventions: MRI was done preoperatively and surgery was either breast conservation surgery or mastectomy. Results: 200 (45%) of the 441 (45%) MRI patients had a new lesions found; 131 of these patients had additional imaging and 67 had a biopsy for a suspicious lesion. Of these 678 patients, 42% had an additional malignancy found. Thus, 15% of the 441 patients had additional preoperative biopsies. A total of 117 patients (29%) had a change in surgical plan based on the MRI results. Fifty-one patients had a mastectomy after a plan for breast conservation therapy had been set, and 65% of patients with no further biopsy to confirm multicentric disease had unicentric disease on final pathology. The size of the MRI lesion and the presence of a new lesion were the only 2 criteria that correlated with a change in treatment plan. The mastectomy rate for MRI patients was 44% compared to 32% for the non-MRI patients. Conclusions: Breast MRI increases mastectomy rates, and biopsy of MRI-identified lesions is necessary to avoid over-treatment. Reviewer's Comments: Breast MRI screening criteria have specific guidelines. The use of MRI after a diagnosis of breast cancer is made is less defined. While MRI detects new lesions in the ipsilateral and contralateral breast, the clinical significance of the lesions remains unclear. No strong evidence exists that more aggressive surgery for the MRI lesions improves patients' outcomes. These authors suggest that MRI use does drive mastectomy rates to increase. They document over-treatment based on unicentric disease found on pathology when the MRI suggested multicentric disease. They caution against using MRI to direct therapy without secondary studies, including biopsy of the MRI lesions. Sound judgment as this imaging technique creeps into the mainstream of breast cancer management. (Reviewer-John A. Weigelt, MD).
